| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/01/2000 | US6096319 Peptides with amino acid sequences |
| 08/01/2000 | US6096318 Antigenically modified HCG polypeptides |
| 08/01/2000 | US6096315 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 08/01/2000 | US6096314 Peptides and pharmaceutical compositions comprising them |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | US6096306 Strains of Bacillus thuringiensis and pesticide composition containing them |
| 08/01/2000 | US6096305 Receptor that binds IL-17 |
| 08/01/2000 | US6096304 Neurotoxins coding nucleotide sequences for gene expression |
| 08/01/2000 | US6096300 Suppression of myeloproliferation and anticarcinogenic agents |
| 08/01/2000 | CA2201601C Chimeric papillomavirus-like particles |
| 08/01/2000 | CA2199832C Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 08/01/2000 | CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 08/01/2000 | CA2185436C Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
| 08/01/2000 | CA2184004C Production of fibrinogen in transgenic animals |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2134240C Novel peptide having elastase inhibitor activity and process for producing the same |
| 08/01/2000 | CA2127091C Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 08/01/2000 | CA2123786C Method of treating viral infections with c-reactive protein |
| 08/01/2000 | CA2099976C Repressors of the trans-activating function of papillomavirus e2 proteins |
| 08/01/2000 | CA2047717C Monoclonal antibodies for small moieties, methods therefor |
| 08/01/2000 | CA2025350C Process for production of c-terminal .alpha.-amidated peptide |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 08/01/2000 | CA1341070C Pulmonary surfactant protein and related polypeptide |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 08/01/2000 | CA1341064C Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions |
| 07/29/2000 | CA2297137A1 New gene with down-regulated expression in metastatic human melanoma cells and a protein coded thereby, methods of production, and use thereof |
| 07/29/2000 | CA2291962A1 Glucose regulated gene |
| 07/29/2000 | CA2258973A1 Glucose regulated gene |
| 07/29/2000 | CA2258972A1 Apoptosis inhibitory protein, gene encoding the protein and cdna thereof |
| 07/27/2000 | WO2000043791A2 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 07/27/2000 | WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/27/2000 | WO2000043782A2 Removal of prions from blood, plasma and other liquids |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043549A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | WO2000043528A1 Megsin promoter |
| 07/27/2000 | WO2000043527A1 Varicella-zoster virus vaccines |
| 07/27/2000 | WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | WO2000043521A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 07/27/2000 | WO2000043520A2 Materials and methods for producing geminivirus resistant plants |
| 07/27/2000 | WO2000043519A2 Neisseria meningitidis polypeptides |
| 07/27/2000 | WO2000043518A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043516A1 Zsig67: a member of the human secretin-glucagon-vip hormone family |
| 07/27/2000 | WO2000043514A2 Human acid sensing ion channel and uses thereof |
| 07/27/2000 | WO2000043513A1 17723 receptor, a g-protein coupled receptor |
| 07/27/2000 | WO2000043512A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043510A2 Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use |
| 07/27/2000 | WO2000043509A2 Polynucleotides and their applications in diagnostics |
| 07/27/2000 | WO2000043508A2 Cancer-associated proteins |
| 07/27/2000 | WO2000043506A1 Novel nucleic acid and amino acid sequences |
| 07/27/2000 | WO2000043497A1 Gibberellin producing and plant growth stimulating bacteria |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043494A2 Control of virus infection using replication associated proteins, compositions and methods of use |
| 07/27/2000 | WO2000043492A2 Method of site specific labeling of proteins and uses therefor |
| 07/27/2000 | WO2000043491A2 yhxB |
| 07/27/2000 | WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/27/2000 | WO2000043421A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043420A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043412A1 Compositions containing highly purified heparin cofactor ii and method for separating the same |
| 07/27/2000 | WO2000043410A2 Novel odorant receptors in drosophila |
| 07/27/2000 | WO2000043409A2 Alpha-conotoxin peptides |
| 07/27/2000 | WO2000043332A2 Biopolymers comprising human immunodeficiency virus tat |
| 07/27/2000 | WO2000043039A1 Vaccine-mediated treatment of neurological disorders |
| 07/27/2000 | WO2000043037A2 Hiv-encoded chemoattractant |
| 07/27/2000 | WO2000043036A2 Lipoprotein complexes and compositions containing them |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043031A1 Tumor necrosis factor antagonists and their use in endometriosis |
| 07/27/2000 | WO2000043029A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | WO2000043028A2 Method of treating chronic cardiac disease |
| 07/27/2000 | WO2000043027A1 Application of a viral complement inhibitory protein in the treatment and diagnosis of alzheimer's disease |
| 07/27/2000 | WO2000043026A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 07/27/2000 | WO2000042973A2 Homing pro-apoptotic conjugates and methods of using same |
| 07/27/2000 | WO2000042855A1 Biological control of nematodes |
| 07/27/2000 | WO2000031281A3 Dna sequence encoding a glutamate/malate translocator, plasmids, bacteria, yeasts and plants containing said transporter |
| 07/27/2000 | WO2000031261A3 Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor |
| 07/27/2000 | WO2000027883A3 A method of treating tumors using fas-induced apoptosis |
| 07/27/2000 | WO2000027875A3 Activity dependent neurotrophic factor iii (adnf iii) |
| 07/27/2000 | WO2000025814A3 Component for vaccine against serogroup b meningococci |
| 07/27/2000 | WO2000023593A3 Molecular pathogenicide mediated plant disease resistance |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000023096A3 Combination therapy with vip antagonist |
| 07/27/2000 | WO2000023094A3 Methods of inhibiting platelet activation and recruitment |
| 07/27/2000 | WO2000022001A8 A potassium channel of the erg family |
| 07/27/2000 | WO2000021553A3 Method of regulating smn gene expression |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000018909A3 NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) |
| 07/27/2000 | WO2000017328A3 Fibrils |
| 07/27/2000 | WO2000017225A3 A small protein that interacts with a ribonucleotide reductase subunit and uses thereof |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000010673A8 Apparatus and method for capturing particles with surface exposure of anionic phospholipids from biological fluids |
| 07/27/2000 | WO2000009712A8 Transcription factors regulating the expression of ethylene-inducible genes |
| 07/27/2000 | WO2000009699A9 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 07/27/2000 | WO2000009533A9 Dna encoding canine von willebrand factor and methods of use |
| 07/27/2000 | WO2000006763A9 Fusion products containing insoluble proteinaceous tag |
| 07/27/2000 | WO2000005253A9 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 07/27/2000 | WO2000002899A9 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 07/27/2000 | WO2000002523A9 Vaccine against staphylococcus intoxication |